{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:21:16Z","timestamp":1784193676839,"version":"3.55.0"},"reference-count":180,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Ocular melanomas, comprising uveal melanoma (UM) and conjunctival melanoma (CoM), represent the most common primary intraocular and ocular surface malignancies in adults. Although rare compared with cutaneous melanoma, they exhibit unique molecular landscapes that provide critical opportunities for biomarker-driven precision medicine. In UM, recurrent mutations in GNAQ and GNA11, together with alterations in BAP1, SF3B1, and EIF1AX, have emerged as key prognostic biomarkers that stratify metastatic risk and guide surveillance strategies. Conversely, in CoM, the mutational spectrum overlaps with cutaneous melanoma, with frequent alterations in BRAF, NRAS, NF1, and KIT, offering actionable targets for personalised treatment. Beyond genomics, epigenetic signatures, microRNAs, and protein-based markers provide further insights into tumour progression, microenvironmental remodelling, and immune evasion. In parallel, liquid biopsy has emerged as a minimally invasive approach for real-time disease monitoring. Analyses of circulating tumour DNA (ctDNA), circulating tumour cells (CTCs), and exosome-derived microRNAs demonstrate increasing potential for early detection of minimal residual disease, prognostic assessment, and evaluation of treatment response. However, the clinical integration of these biomarkers remains limited by tumour heterogeneity, technical variability, and the lack of unified translational frameworks. This review synthesises current knowledge of molecular and liquid biopsy biomarkers in ocular melanoma, highlighting their relevance for diagnosis, prognosis, and treatment personalisation. The integration of established tissue-based molecular markers with novel liquid biopsy technologies will enable a unique framework for biomarker-guided precision oncology and risk-adapted surveillance in uveal and conjunctival melanoma, offering insight into strategies for early detection, therapeutic monitoring, and personalised clinical management.<\/jats:p>","DOI":"10.3390\/cimb48020131","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T08:14:23Z","timestamp":1769415263000},"page":"131","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Precision Oncology in Ocular Melanoma: Integrating Molecular and Liquid Biopsy Biomarkers"],"prefix":"10.3390","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3983-1157","authenticated-orcid":false,"given":"Snje\u017eana","family":"Ka\u0161telan","sequence":"first","affiliation":[{"name":"Clinical Hospital Dubrava, Department of Ophthalmology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3336-3169","authenticated-orcid":false,"given":"Fanka","family":"Gilevska","sequence":"additional","affiliation":[{"name":"Promedika Ophthalmology Hospital, 1000 Skopje, North Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-9254","authenticated-orcid":false,"given":"Zora","family":"Tomi\u0107","sequence":"additional","affiliation":[{"name":"Health Centre of the Croatian Department of Internal Affairs, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7297-5366","authenticated-orcid":false,"given":"Josipa","family":"\u017divko","sequence":"additional","affiliation":[{"name":"Clinical Hospital Merkur, Clinical Department of Diagnostic and Interventional Radiology, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Niku\u0161eva-Marti\u0107","sequence":"additional","affiliation":[{"name":"Department of Biology and Genetics, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Iavarone, L., Franco, R., Zito Marino, F., D\u2019Abbronzo, G., Argenziano, G., Scharf, C., Nucci, G., Ronchi, A., and Cazzato, G. (2025). Ocular Melanoma: A Comprehensive Review with a Focus on Molecular Biology. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199799"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.32604\/or.2024.048437","article-title":"Biological Characteristics and Clinical Management of Uveal and Conjunctival Melanoma","volume":"32","author":"Konjevoda","year":"2024","journal-title":"Oncol. Res."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ka\u0161telan, S., Mrazovac Zimak, D., Ivi\u0107, L., Gverovi\u0107 Antunica, A., and Niku\u0161eva-Marti\u0107, T. (2025). Conjunctival Melanoma: Comprehensive Insights into Clinical Features, Genetic Alterations, and Modern Treatment Approaches. Pathol. Oncol. Res., 31.","DOI":"10.3389\/pore.2025.1612085"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kulbay, M., Marcotte, E., Remtulla, R., Lau, T.H.A., Paez-Escamilla, M., Wu, K.Y., and Burnier, M.N. (2024). Uveal Melanoma: Comprehensive Review of Its Pathophysiology, Diagnosis, Treatment, and Future Perspectives. Biomedicines, 12.","DOI":"10.3390\/biomedicines12081758"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s12253-018-0419-3","article-title":"Conjunctival Melanoma\u2014Epidemiological Trends and Features","volume":"24","author":"Kasun","year":"2018","journal-title":"Pathol. Oncol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Pa\u0161ali\u0107, D., Niku\u0161eva-Marti\u0107, T., Sekovani\u0107, A., and Ka\u0161telan, S. (2023). Genetic and Epigenetic Features of Uveal Melanoma-An Overview and Clinical Implications. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612807"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/iovs.65.10.37","article-title":"Inhibition of Heme Oxygenase 1 Suppresses Growth, Migration, and Invasion, and Regulates Tumor-Infiltrating CD8+ T Cells and in Uveal Melanoma","volume":"65","author":"Hou","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_8","first-page":"1230","article-title":"Ocular Melanoma: An Overview of the Current Status","volume":"6","author":"Jovanovic","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00262-024-03776-5","article-title":"GP100 Expression Is Variable in Intensity in Melanoma","volume":"73","author":"Mann","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal Melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ka\u0161telan, S., Mrazovac Zimak, D., Ivankovi\u0107, M., Markovi\u0107, I., and Gverovi\u0107 Antunica, A. (2022). Liver Metastasis in Uveal Melanoma\u2014Treatment Options and Clinical Outcome. Front. Biosci., 27.","DOI":"10.31083\/j.fbl2702072"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"112900","DOI":"10.1016\/j.ejca.2023.04.016","article-title":"Prognostic and Predictive Value of Metformin in the European Organisation for Research and Treatment of Cancer 1325\/KEYNOTE-054 Phase III Trial of Pembrolizumab versus Placebo in Resected High-Risk Stage III Melanoma","volume":"189","author":"Kennedy","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000480640","article-title":"Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973\u20132013)","volume":"4","author":"Aronow","year":"2018","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","article-title":"Advances in the Clinical Management of Uveal Melanoma","volume":"20","author":"Carvajal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semcancer.2025.10.002","article-title":"The Emerging Role of Metabolic Interventions in Uveal Melanoma","volume":"117","author":"Kuranaga","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100306","DOI":"10.1016\/j.jlb.2025.100306","article-title":"Liquid Biopsy as a Potential Tool for Diagnosis and Clinical Monitoring of Cutaneous and Uveal Melanoma","volume":"9","author":"Ferraz","year":"2025","journal-title":"J. Liq. Biopsy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13046-021-01984-w","article-title":"Circulating Tumor DNA Tracking through Driver Mutations as a Liquid Biopsy-Based Biomarker for Uveal Melanoma","volume":"40","author":"Bustamante","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"21685","DOI":"10.1038\/s41598-023-48501-x","article-title":"Liquid Biopsy: From Concept to Clinical Application","volume":"13","author":"Marchetti","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4103\/joco.joco_88_24","article-title":"Liquid Biopsy and Ocular Tumors: A Review","volume":"36","author":"Chaaya","year":"2024","journal-title":"J. Curr. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"He, Y., Liu, H., Hendgen-Cotta, U., Rassaf, T., Bechrakis, N.E., and Berchner-Pfannschmidt, U. (2025). The Discovery of \u03b1-Adrenoceptor Antagonists as a Potential New Treatment Option for Uveal Melanoma. Biomolecules, 15.","DOI":"10.3390\/biom15101436"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Butt, K., Hussain, R., Coupland, S.E., and Krishna, Y. (2024). Conjunctival Melanoma: A Clinical Review and Update. Cancers, 16.","DOI":"10.20944\/preprints202407.1752.v1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1755-148X.2012.00979.x","article-title":"The Genetics of Uveal Melanoma: An Emerging Framework for Targeted Therapy","volume":"25","author":"Harbour","year":"2012","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Silva-Rodr\u00edguez, P., Fern\u00e1ndez-D\u00edaz, D., Bande, M., Pardo, M., Loidi, L., and Blanco-Teijeiro, M.J. (2022). GNAQ and GNA11 Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma. Cancers, 14.","DOI":"10.3390\/cancers14133066"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Fuentes-Rodriguez, A., Mitchell, A., Gu\u00e9rin, S.L., and Landreville, S. (2024). Recent Advances in Molecular and Genetic Research on Uveal Melanoma. Cells, 13.","DOI":"10.3390\/cells13121023"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"102447","DOI":"10.1016\/j.xcrm.2025.102447","article-title":"Aqueous Humor Biomarkers in Ocular Oncology: Insights and Advances","volume":"6","author":"Cheslow","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41401-020-0441-3","article-title":"Ubiquitin-Proteasome System-Targeted Therapy for Uveal Melanoma: What Is the Evidence?","volume":"42","author":"Zhao","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kaler, C.J., Dollar, J.J., Cruz, A.M., Kuznetsoff, J.N., Sanchez, M.I., Decatur, C.L., Licht, J.D., Smalley, K.S.M., Correa, Z.M., and Kurtenbach, S. (2022). BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas. Cancers, 14.","DOI":"10.20944\/preprints202206.0236.v1"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100971","DOI":"10.1016\/j.preteyeres.2021.100971","article-title":"Conjunctival Melanoma: New Insights in Tumour Genetics and Immunology, Leading to New Therapeutic Options","volume":"86","author":"Brouwer","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Shebrain, A., Idris, O.A., Jawad, A., Zhang, T., and Xing, Y. (2024). Advancements and Challenges in Personalized Therapy for BRAF-Mutant Melanoma: A Comprehensive Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13185409"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Flick, K.M., Demirci, H., and Demirci, F.Y. (2024). Epigenetics of Conjunctival Melanoma: Current Knowledge and Future Directions. Cancers, 16.","DOI":"10.3390\/cancers16213687"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.trecan.2025.04.007","article-title":"Epigenetic Mechanisms in Melanoma Development and Progression","volume":"11","author":"Joo","year":"2025","journal-title":"Trends Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"155081","DOI":"10.1016\/j.prp.2023.155081","article-title":"From Diagnosis to Therapy: The Transformative Role of lncRNAs in Eye Cancer Management","volume":"254","author":"Hazazi","year":"2024","journal-title":"Pathol.-Res. Pract."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Varela, M., Villatoro, S., Lorenzo, D., Piulats, J.M., and Caminal, J.M. (2024). Optimizing ctDNA: An Updated Review of a Promising Clinical Tool for the Management of Uveal Melanoma. Cancers, 16.","DOI":"10.3390\/cancers16173053"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12943-024-02081-0","article-title":"Exosomal miRNAs: The Tumor\u2019s Trojan Horse in Selective Metastasis","volume":"23","author":"Bayat","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00018-020-03612-w","article-title":"Emerging Roles of microRNAs and Their Implications in Uveal Melanoma","volume":"78","author":"Yang","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ajo.2025.06.049","article-title":"Comparison of Patients With Observed High-Risk Choroidal Nevi That Evolved into Melanomas vs Patients with Immediately Treated Uveal Melanomas","volume":"278","author":"Kadakia","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"ref_37","first-page":"16","article-title":"Mucosal Malignant Melanoma in Upper Aerodigestive Tract: Report of Two Cases","volume":"46","author":"Oktay","year":"2004","journal-title":"Acta Chir. Plast."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"100293","DOI":"10.1016\/j.jlb.2025.100293","article-title":"The Growing Field of Liquid Biopsy and Its Snowball Effect on Reshaping Cancer Management","volume":"8","author":"Borea","year":"2025","journal-title":"J. Liq. Biopsy"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000518219","article-title":"TERT Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy","volume":"238","author":"Martins","year":"2022","journal-title":"Dermatology"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"de Bruyn, D.P., Beasley, A.B., Verdijk, R.M., van Poppelen, N.M., Paridaens, D., de Keizer, R.O.B., Naus, N.C., Gray, E.S., de Klein, A., and Brosens, E. (2022). Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020506"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000508613","article-title":"Liquid Biopsy in Uveal Melanoma: Are We There Yet?","volume":"7","author":"Jin","year":"2021","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-021-01336-4","article-title":"Liquid Biopsy Proteomics of Uveal Melanoma Reveals Biomarkers Associated with Metastatic Risk","volume":"20","author":"Velez","year":"2021","journal-title":"Mol. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/OPTH.S199064","article-title":"Blood Biomarkers of Uveal Melanoma: Current Perspectives","volume":"14","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12015-022-10358-4","article-title":"Exosomal microRNA-4535 of Melanoma Stem Cells Promotes Metastasis by Inhibiting Autophagy Pathway","volume":"19","author":"Liu","year":"2023","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bjophthalmol-2019-314867","article-title":"Heterogeneity of GNAQ\/11 Mutation Inversely Correlates with the Metastatic Rate in Uveal Melanoma","volume":"105","author":"Liang","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2022.04.013","article-title":"In Uveal Melanoma G\u03b1-Protein GNA11 Mutations Convey a Shorter Disease-Specific Survival and Are More Strongly Associated with Loss of BAP1 and Chromosomal Alterations than G\u03b1-Protein GNAQ Mutations","volume":"170","author":"Piaggio","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s12276-023-00979-1","article-title":"BAP1 as a Guardian of Genome Stability: Implications in Human Cancer","volume":"55","author":"Kwon","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Gallenga, C.E., Franco, E., Adamo, G.G., Violanti, S.S., Tassinari, P., Tognon, M., and Perri, P. (2022). Genetic Basis and Molecular Mechanisms of Uveal Melanoma Metastasis: A Focus on Prognosis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.828112"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"102327","DOI":"10.1016\/j.ajoc.2025.102327","article-title":"Co-Occurrence of EIF1AX, SF3B1, or BAP1 Variants in Uveal Melanomas: A Case Series and Review","volume":"38","author":"Skrehot","year":"2025","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Drabarek, W., van Riet, J., Nguyen, J.Q.N., Smit, K.N., van Poppelen, N.M., Jansen, R., Medico-Salsench, E., Vaarwater, J., Magielsen, F.J., and Brands, T. (2022). Identification of Early-Onset Metastasis in SF3B1 Mutated Uveal Melanoma. Cancers, 14.","DOI":"10.3390\/cancers14030846"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Nell, R.J., Menger, N.V., Versluis, M., Luyten, G.P.M., Verdijk, R.M., Madigan, M.C., Jager, M.J., and van der Velden, P.A. (2021). Involvement of Mutant and Wild-Type CYSLTR2 in the Development and Progression of Uveal Nevi and Melanoma. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-07865-x"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"eabj4243","DOI":"10.1126\/scisignal.abj4243","article-title":"Uveal Melanoma-Associated Mutations in PLC\u03b24 Are Constitutively Activating and Promote Melanocyte Proliferation and Tumorigenesis","volume":"14","author":"Phan","year":"2021","journal-title":"Sci. Signal."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41388-020-01569-5","article-title":"Functional Characterization of Uveal Melanoma Oncogenes","volume":"40","author":"Ma","year":"2021","journal-title":"Oncogene"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/iovs.64.1.15","article-title":"Cytogenetic Abnormalities for Predicting the Risk of Metastases in Choroidal and Ciliary Body Melanoma","volume":"64","author":"Chao","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1200\/JCO.24.00447","article-title":"15-Gene Expression Profile and PRAME as Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1)","volume":"42","author":"Harbour","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.5384","article-title":"Loss of BAP1 Expression Is Associated with an Immunosuppressive Microenvironment in Uveal Melanoma, with Implications for Immunotherapy Development","volume":"250","author":"Figueiredo","year":"2020","journal-title":"J. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1056\/NEJMoa2304753","article-title":"Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma","volume":"389","author":"Hassel","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"17588359231160140","DOI":"10.1177\/17588359231160140","article-title":"Tebentafusp: A First-in-Class Treatment for Metastatic Uveal Melanoma","volume":"15","author":"Howlett","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s43556-024-00182-2","article-title":"Heterogeneity and Molecular Landscape of Melanoma: Implications for Targeted Therapy","volume":"5","author":"Beigi","year":"2024","journal-title":"Mol. Biomed."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41467-020-15606-0","article-title":"Molecular Profiling of Driver Events in Metastatic Uveal Melanoma","volume":"11","author":"Karlsson","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"100800","DOI":"10.1016\/j.preteyeres.2019.100800","article-title":"Uveal Melanoma: Towards a Molecular Understanding","volume":"75","author":"Smit","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2174\/0929867326666190704141444","article-title":"Immunotherapy for Uveal Melanoma\u2014Current Knowledge and Perspectives","volume":"27","author":"Antunica","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11912-025-01684-0","article-title":"State-of-the-Art in Metastatic Uveal Melanoma Treatment: A 2025 Update: How to Treat Metastatic Uveal Melanoma in 2025","volume":"27","author":"Ziogas","year":"2025","journal-title":"Curr. Oncol. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Gardrat, S., Houy, A., Brooks, K., Cassoux, N., Barnhill, R., Dayot, S., Bi\u00e8che, I., Raynal, V., Baulande, S., and Marais, R. (2021). Definition of Biologically Distinct Groups of Conjunctival Melanomas According to Etiological Factors and Implications for Precision Medicine. Cancers, 13.","DOI":"10.3390\/cancers13153836"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-13-0163","article-title":"Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas","volume":"19","author":"Griewank","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.2147\/OPTH.S271569","article-title":"Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies","volume":"14","author":"Gkiala","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Bol, K.F., Donia, M., Heegaard, S., Kiilgaard, J.F., and Svane, I.M. (2020). Genetic Biomarkers in Melanoma of the Ocular Region: What the Medical Oncologist Should Know. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155231"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"16367","DOI":"10.1038\/s41598-020-73534-x","article-title":"Clinical Features and Survival Outcomes of Ocular Melanoma in a Multi-Ethnic Asian Cohort","volume":"10","author":"Tan","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1167\/iovs.16-19862","article-title":"MicroRNA Expression Profile in Conjunctival Melanoma","volume":"57","author":"Larsen","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"77163","DOI":"10.18632\/oncotarget.12848","article-title":"Co-Existence of BRAF and NRAS Driver Mutations in the Same Melanoma Cells Results in Heterogeneity of Targeted Therapy Resistance","volume":"7","author":"Raaijmakers","year":"2016","journal-title":"Oncotarget"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Cisarova, K., Folcher, M., El Zaoui, I., Pescini-Gobert, R., Peter, V.G., Royer-Bertrand, B., Zografos, L., Schalenbourg, A., Nicolas, M., and Rimoldi, D. (2020). Genomic and Transcriptomic Landscape of Conjunctival Melanoma. PLoS Genet., 16.","DOI":"10.1371\/journal.pgen.1009201"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Chang, E., Demirci, H., and Demirci, F.Y. (2023). Genetic Aspects of Conjunctival Melanoma: A Review. Genes, 14.","DOI":"10.3390\/genes14091668"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jamaophthalmol.2019.4237","article-title":"Integrative Exome and Transcriptome Analysis of Conjunctival Melanoma and Its Potential Application for Personalized Therapy","volume":"137","author":"Demirci","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ophtha.2022.01.016","article-title":"Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients","volume":"129","author":"Lally","year":"2022","journal-title":"Ophthalmology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41416-018-0046-5","article-title":"NF1 Mutations in Conjunctival Melanoma","volume":"118","author":"Scholz","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"van Poppelen, N.M., van Ipenburg, J.A., van den Bosch, Q., Vaarwater, J., Brands, T., Eussen, B., Magielsen, F., Dubbink, H.J., Paridaens, D., and Brosens, E. (2021). Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115784"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ophtha.2019.10.008","article-title":"MicroRNA Profiling in Benign and Malignant Conjunctival Melanocytic Lesions","volume":"127","author":"Dorssers","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"405","DOI":"10.18502\/jovr.v17i3.11579","article-title":"Update on Immune Checkpoint Inhibitors for Conjunctival Melanoma","volume":"17","author":"Sa","year":"2022","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e004485","DOI":"10.1136\/jitc-2021-004485","article-title":"Detection of Microsatellite Instability-High (MSI-H) by Liquid Biopsy Predicts Robust and Durable Response to Immunotherapy in Patients with Pancreatic Cancer","volume":"10","author":"Chakrabarti","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00262-025-03980-x","article-title":"Microsatellite Instability-High Status as a Pan-Cancer Biomarker for Immunotherapy Efficacy","volume":"74","author":"Landre","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/bjo.2009.174417","article-title":"Analysis of GNAQ Mutations, Proliferation and MAPK Pathway Activation in Uveal Melanomas","volume":"95","author":"Vinagre","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Scoles, S., Ganesh, S., and Yamada, K.H. (2025). Current Therapies and Potential Strategies for Uveal Melanoma. Drugs Drug Candidates, 4.","DOI":"10.3390\/ddc4020014"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.preteyeres.2009.06.002","article-title":"Immune Escape Mechanisms of Intraocular Tumors","volume":"28","author":"Niederkorn","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Lamas-Francis, D., Rodr\u00edguez-Fern\u00e1ndez, C.A., de Esteban-Maci\u00f1eira, E., Silva-Rodr\u00edguez, P., Pardo, M., Bande-Rodr\u00edguez, M., and Blanco-Teijeiro, M.J. (2024). Impact of Driver Mutations on Metastasis-Free Survival in Uveal Melanoma: A Meta-Analysis. Cancers, 16.","DOI":"10.3390\/cancers16142510"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ajo.2024.10.012","article-title":"Circulating Tumor DNA in Conjunctival Melanoma: Landscape and Surveillance Value","volume":"270","author":"Tian","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/dermatopathology8020023","article-title":"5-Hydroxymethylcytosine Loss in Conjunctival Melanoma","volume":"8","author":"Stahl","year":"2021","journal-title":"Dermatopathology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12943-019-1088-x","article-title":"m6A Modification Suppresses Ocular Melanoma through Modulating HINT2 mRNA Translation","volume":"18","author":"Jia","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.ymthe.2021.02.014","article-title":"M(6)A RNA Hypermethylation-Induced BACE2 Boosts Intracellular Calcium Release and Accelerates Tumorigenesis of Ocular Melanoma","volume":"29","author":"He","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"216911","DOI":"10.1016\/j.canlet.2024.216911","article-title":"FTO Elicits Tumor Neovascularization in Cancer-Associated Fibroblasts through Eliminating m6A Modifications of Multiple pro-Angiogenic Factors","volume":"592","author":"Liao","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/path.5094","article-title":"Overexpression of EZH2 in Conjunctival Melanoma Offers a New Therapeutic Target","volume":"245","author":"Cao","year":"2018","journal-title":"J. Pathol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jb\/mvab007","article-title":"Targeting EZH2 as Cancer Therapy","volume":"170","author":"Hanaki","year":"2021","journal-title":"J. Biochem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41698-021-00226-8","article-title":"BAP1 Methylation: A Prognostic Marker of Uveal Melanoma Metastasis","volume":"5","author":"Bakhoum","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41598-021-03964-8","article-title":"Genome-Wide Aberrant Methylation in Primary Metastatic UM and Their Matched Metastases","volume":"12","author":"Smit","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Yang, L., Wang, G., Shi, H., Jia, S., Ruan, J., Cui, R., and Ge, S. (2022). Methylation-Driven Gene DLL3 Is a Potential Prognostic Biomarker in Ocular Melanoma Correlating with Metastasis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.964902"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e1317","DOI":"10.1002\/ctm2.1317","article-title":"Uncovering Accurate Prognostic Markers for High-Risk Uveal Melanoma through DNA Methylation Profiling","volume":"13","author":"Soltysova","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Lalonde, E., Li, D., Ewens, K., Shields, C.L., and Ganguly, A. (2024). Genome-Wide Methylation Patterns in Primary Uveal Melanoma: Development of MethylSig-UM, an Epigenomic Prognostic Signature to Improve Patient Stratification. Cancers, 16.","DOI":"10.3390\/cancers16152650"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2217\/epi-2019-0029","article-title":"Altered Expression Profile of Circular RNAs in Conjunctival Melanoma","volume":"11","author":"Shang","year":"2019","journal-title":"Epigenomics"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/CMR.0000000000000606","article-title":"Global microRNA Profiling of Metastatic Conjunctival Melanoma","volume":"29","author":"Mikkelsen","year":"2019","journal-title":"Melanoma Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/CMR.0b013e3282feeac6","article-title":"Micro-RNAs Associated with Metastasis in Uveal Melanoma Identified by Multiplexed Microarray Profiling","volume":"18","author":"Worley","year":"2008","journal-title":"Melanoma Res."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Venkatesan, N., Kanwar, J., Deepa, P.R., Khetan, V., Crowley, T.M., Raguraman, R., Sugneswari, G., Rishi, P., Natarajan, V., and Biswas, J. (2016). Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3\/Disomy 3 Chromosomal Aberrations. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146128"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.exer.2019.01.004","article-title":"Identification of a Nine-miRNA Signature for the Prognosis of Uveal Melanoma","volume":"180","author":"Xin","year":"2019","journal-title":"Exp. Eye Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.8.6.12","article-title":"A Panel of Circulating MicroRNAs Detects Uveal Melanoma With High Precision","volume":"8","author":"Stark","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Russo, A., Caltabiano, R., Longo, A., Avitabile, T., Franco, L.M., Bonfiglio, V., Puzzo, L., and Reibaldi, M. (2016). Increased Levels of miRNA-146a in Serum and Histologic Samples of Patients with Uveal Melanoma. Front. Pharmacol., 7.","DOI":"10.3389\/fphar.2016.00424"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbagrm.2015.06.015","article-title":"lncRNAs and microRNAs with a Role in Cancer Development","volume":"1859","author":"Liz","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1167\/iovs.19-27704","article-title":"Long Noncoding RNA PVT1 Silencing Prevents the Development of Uveal Melanoma by Impairing MicroRNA-17-3p-Dependent MDM2 Upregulation","volume":"60","author":"Wu","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"104119","DOI":"10.1016\/j.cellimm.2020.104119","article-title":"The Roles of Tumor-Associated Macrophages in Tumor Angiogenesis and Metastasis","volume":"353","author":"Fu","year":"2020","journal-title":"Cell Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2147\/OPTH.S184193","article-title":"Expression of VEGF in Human Conjunctival Melanoma Analyzed with Immunohistochemistry","volume":"12","author":"Kase","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10456-024-09930-y","article-title":"Lactate Secreted by Glycolytic Conjunctival Melanoma Cells Attracts and Polarizes Macrophages to Drive Angiogenesis in Zebrafish Xenografts","volume":"27","author":"Yin","year":"2024","journal-title":"Angiogenesis"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1167\/iovs.10-5979","article-title":"Detection of M2-Macrophages in Uveal Melanoma and Relation with Survival","volume":"52","author":"Bronkhorst","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1007\/s10792-023-02830-y","article-title":"Factors Affecting Recurrence and Metastasis in Conjunctival Melanoma","volume":"43","year":"2023","journal-title":"Int. Ophthalmol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Brouwer, N.J., Gezgin, G., Wierenga, A.P.A., Bronkhorst, I.H.G., Marinkovic, M., Luyten, G.P.M., Versluis, M., Kroes, W.G.M., van der Velden, P.A., and Verdijk, R.M. (2019). Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution. Cancers, 11.","DOI":"10.3390\/cancers11070979"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"26811","DOI":"10.1038\/s41598-024-78171-2","article-title":"Revealing the Structural Microenvironment of High Metastatic Risk Uveal Melanomas Following Decellularisation","volume":"14","author":"Aughton","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e749","DOI":"10.1016\/j.jcjo.2023.12.002","article-title":"Prognostic Implications of Tenascin C in Peripheral Blood and Primary Tumours at the Time of Uveal Melanoma Diagnosis","volume":"59","author":"Herrspiegel","year":"2024","journal-title":"Can. J. Ophthalmol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12935-025-03959-9","article-title":"The Association between Periostin and Tumor Microenvironment: A Promising Cancer Prognostic Biomarker and Therapeutic Target to Combat Tumor Progression and Chemoresistance","volume":"25","author":"Farzam","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/s41416-022-01723-8","article-title":"Future Perspectives of Uveal Melanoma Blood Based Biomarkers","volume":"126","author":"Beasley","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00279","article-title":"Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma","volume":"2","author":"Beasley","year":"2018","journal-title":"JCO Precis. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e12120","DOI":"10.1002\/jev2.12120","article-title":"Synthetic Bacterial Vesicles Combined with Tumour Extracellular Vesicles as Cancer Immunotherapy","volume":"10","author":"Park","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e70051","DOI":"10.1111\/pcmr.70051","article-title":"Many Faces of Melanoma: A Comparison Between Cutaneous, Mucosal, Acral, Nail, and Ocular Malignancy","volume":"38","author":"Nowowiejska","year":"2025","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Martel, A., Baillif, S., Nahon-Esteve, S., Gastaud, L., Bertolotto, C., Rom\u00e9o, B., Mograbi, B., Lassalle, S., and Hofman, P. (2020). Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives. Cancers, 12.","DOI":"10.3390\/cancers12113284"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/08820538.2025.2484228","article-title":"Intraocular Tumor Biopsy","volume":"41","author":"Chauhan","year":"2026","journal-title":"Semin. Ophthalmol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Martins, I., Ribeiro, I.P., Jorge, J., Gon\u00e7alves, A.C., Sarmento-Ribeiro, A.B., Melo, J.B., and Carreira, I.M. (2021). Liquid Biopsies: Applications for Cancer Diagnosis and Monitoring. Genes, 12.","DOI":"10.3390\/genes12030349"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"217531","DOI":"10.1016\/j.canlet.2025.217531","article-title":"Extracellular Vesicles in Uveal Melanoma\u2014Biological Roles and Diagnostic Value","volume":"615","author":"Crescitelli","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_124","unstructured":"Food and Drug Administration, and HHS (2004). Medical Devices; Immunology and Microbiology Devices; Classification of the Immunomagnetic Circulating Cancer Cell Selection and Enumeration System. Final Rule. Fed. Regist., 69, 26036\u201326038."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/s41591-025-04093-9","article-title":"Liquid Biopsies across the Cancer Care Continuum","volume":"31","author":"Landon","year":"2025","journal-title":"Nat. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.33393\/jcb.2023.2629","article-title":"Analytical Performance of the FDA-Cleared Parsortix(\u00ae) PC1 System","volume":"12","author":"Templeman","year":"2023","journal-title":"J. Circ. Biomark."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Martel, A., Gastaud, L., Bonnetaud, C., Nahon-Esteve, S., Washetine, K., Bordone, O., Salah, M., Tanga, V., Fayada, J., and Lespinet, V. (2023). Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank. Cancers, 15.","DOI":"10.3390\/cancers15082372"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Anand, K., Roszik, J., Gombos, D., Upshaw, J., Sarli, V., Meas, S., Lucci, A., Hall, C., and Patel, S. (2019). Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma. Cancers, 11.","DOI":"10.3390\/cancers11060856"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/ijc.28436","article-title":"Detection Rate and Prognostic Value of Circulating Tumor Cells and Circulating Tumor DNA in Metastatic Uveal Melanoma","volume":"134","author":"Bidard","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1167\/iovs.14-14512","article-title":"Identification of Circulating Melanoma Cells in Uveal Melanoma Patients by Dual-Marker Immunoenrichment","volume":"55","author":"Tura","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Spiliopoulou, P., Holanda Lopes, C.D., and Spreafico, A. (2023). Promising and Minimally Invasive Biomarkers: Targeting Melanoma. Cells, 13.","DOI":"10.3390\/cells13010019"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/gtmb.2018.0237","article-title":"Liquid Biopsy in Solid Malignancy","volume":"23","author":"Scarlotta","year":"2019","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/cam4.61","article-title":"Ultradeep Sequencing Detects GNAQ and GNA11 Mutations in Cell-Free DNA from Plasma of Patients with Uveal Melanoma","volume":"2","author":"Metz","year":"2013","journal-title":"Cancer Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1158\/1078-0432.CCR-06-2329","article-title":"Circulating Tumor Cells as Prognostic Factor for Distant Metastases and Survival in Patients with Primary Uveal Melanoma","volume":"13","author":"Schuster","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000328283","article-title":"Prognostic Relevance of Circulating Tumor Cells in Metastatic Uveal Melanoma","volume":"80","author":"Schuster","year":"2011","journal-title":"Oncology"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1158\/1078-0432.CCR-0610-3","article-title":"Quantitative Detection of Circulating Tumor Cells in Cutaneous and Ocular Melanoma and Quality Assessment by Real-Time Reverse Transcriptase-Polymerase Chain Reaction","volume":"10","author":"Keilholz","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Matull, J., Placke, J.-M., Lodde, G., Zaremba, A., Utikal, J., Terheyden, P., Pf\u00f6hler, C., Herbst, R., Kreuter, A., and Welzel, J. (2024). Clinical and Genetic Characteristics of BAP1-Mutated Non-Uveal and Uveal Melanoma. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1383125"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Wr\u00f3blewska, J.P., Lach, M.S., Rucinski, M., Piotrowski, I., Galus, L., Suchorska, W.M., Kreis, S., and Marsza\u0142ek, A. (2022). MiRNAs from Serum-Derived Extracellular Vesicles as Biomarkers for Uveal Melanoma Progression. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.1008901"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Almeida, C., Teixeira, A.L., Dias, F., Morais, M., and Medeiros, R. (2023). Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management. Biology, 12.","DOI":"10.3390\/biology12050665"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","article-title":"Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm. Res."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Johnson, V., Vasu, S., Kumar, U.S., and Kumar, M. (2023). Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy. Cancers, 15.","DOI":"10.3390\/cancers15102838"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1159\/000493969","article-title":"Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA","volume":"63","author":"Batista","year":"2019","journal-title":"Acta Cytol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"36","DOI":"10.33393\/jcb.2022.2370","article-title":"Characterization of Extracellular Vesicles Isolated from Different Liquid Biopsies of Uveal Melanoma Patients","volume":"11","author":"Pessuti","year":"2022","journal-title":"J. Circ. Biomark."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Surman, M., Hoja-\u0141ukowicz, D., Szwed, S., K\u0119dracka-Krok, S., Jankowska, U., Kurtyka, M., Dro\u017cd\u017c, A., Lity\u0144ska, A., St\u0119pie\u0144, E., and Przyby\u0142o, M. (2019). An Insight into the Proteome of Uveal Melanoma-Derived Ectosomes Reveals the Presence of Potentially Useful Biomarkers. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153789"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1038\/emboj.2012.183","article-title":"Tumour-Secreted miR-9 Promotes Endothelial Cell Migration and Angiogenesis by Activating the JAK-STAT Pathway","volume":"31","author":"Zhuang","year":"2012","journal-title":"Embo J."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41568-022-00536-4","article-title":"Biology, Vulnerabilities and Clinical Applications of Circulating Tumour Cells","volume":"23","author":"Ring","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e009028","DOI":"10.1136\/jitc-2024-009028","article-title":"Long-Term Survival Follow-up for Tebentafusp in Previously Treated Metastatic Uveal Melanoma","volume":"12","author":"Sacco","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40257-024-00872-1","article-title":"The Current State of Systemic Therapy of Metastatic Uveal Melanoma","volume":"25","author":"Koch","year":"2024","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"oyaf323","DOI":"10.1093\/oncolo\/oyaf323","article-title":"Concurrent Local Therapy Extends Clinical Benefit of Tebentafusp in Metastatic Uveal Melanoma Patients","volume":"30","author":"Lim","year":"2025","journal-title":"Oncologist"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1515\/cclm-2025-0271","article-title":"Liquid Biopsy in Oncology: Navigating Technical Hurdles and Future Transition for Precision Medicine","volume":"63","author":"Xie","year":"2025","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/23808993.2018.1421858","article-title":"The Economic Case for Precision Medicine","volume":"3","author":"Gavan","year":"2018","journal-title":"Expert Rev. Precis. Med. Drug Dev."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Dadzie, A.K., Iddir, S.P., Ganesh, S., Ebrahimi, B., Rahimi, M., Abtahi, M., Son, T., Heiferman, M.J., and Yao, X. (2025). Artificial Intelligence in the Diagnosis of Uveal Melanoma: Advances and Applications. Exp. Biol. Med., 250.","DOI":"10.3389\/ebm.2025.10444"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1159\/000548442","article-title":"The Value of Detecting and Monitoring ctDNA in Uveal Melanoma: Results of a Pilot Study and a Systematic Review","volume":"16","author":"Azimi","year":"2025","journal-title":"Case Rep. Ophthalmol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1038\/s41467-024-53145-0","article-title":"Prospective Assessment of Circulating Tumor DNA in Patients with Metastatic Uveal Melanoma Treated with Tebentafusp","volume":"15","author":"Rodrigues","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/iovs.65.2.11","article-title":"Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma","volume":"65","author":"Brands","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"14953","DOI":"10.1007\/s00432-023-05271-3","article-title":"Detection of Metastases Using Circulating Tumour DNA in Uveal Melanoma","volume":"149","author":"Beasley","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/bjo.2009.157933","article-title":"Time Trends in the Incidence of Conjunctival Melanoma in Sweden","volume":"93","author":"Triay","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1167\/iovs.64.13.45","article-title":"Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors","volume":"64","author":"Wu","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"19406","DOI":"10.1038\/s41598-025-03915-7","article-title":"Presence of Tumor DNA in Aqueous Humor Is Correlated with High Risk Uveal Melanoma","volume":"15","author":"Barwinski","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41598-020-57497-7","article-title":"A Comparison of Methods for the Isolation and Separation of Extracellular Vesicles from Protein and Lipid Particles in Human Serum","volume":"10","author":"Brennan","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/bib\/bbz079","article-title":"Circulating microRNA Trafficking and Regulation: Computational Principles and Practice","volume":"21","author":"Cui","year":"2020","journal-title":"Brief. Bioinform."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e006793","DOI":"10.1136\/jitc-2023-006793","article-title":"Challenges in the Implementation of Ultrasensitive Liquid Biopsy Approaches in Precision Oncology","volume":"11","author":"Desai","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1515\/cclm-2023-1157","article-title":"Circulating Tumor DNA: Current Implementation Issues and Future Challenges for Clinical Utility","volume":"62","author":"Hu","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e006284","DOI":"10.1136\/jitc-2022-006284","article-title":"Genomic Approaches to Cancer and Minimal Residual Disease Detection Using Circulating Tumor DNA","volume":"11","author":"Semenkovich","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1515\/cclm-2023-0131","article-title":"Evidence-Based Procedures to Improve the Reliability of Circulating miRNA Biomarker Assays","volume":"62","author":"Greytak","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jval.2024.04.023","article-title":"Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review","volume":"27","author":"Mirza","year":"2024","journal-title":"Value Health"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e23914","DOI":"10.1016\/j.heliyon.2023.e23914","article-title":"Tackling the Implementation Gap for the Uptake of NGS and Advanced Molecular Diagnostics into Healthcare Systems","volume":"10","author":"Horgan","year":"2024","journal-title":"Heliyon"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"217729","DOI":"10.1016\/j.canlet.2025.217729","article-title":"The m6A Hypermethylation-Induced PIR Overexpression Regulates H3K4me3 and Promotes Tumorigenesis of Uveal Melanoma","volume":"623","author":"Tian","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1097\/SLA.0000000000005822","article-title":"Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal Melanoma","volume":"278","author":"Mariani","year":"2023","journal-title":"Ann. Surg."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Zameer, M.Z., Jou, E., and Middleton, M. (2024). The Role of Circulating Tumor DNA in Melanomas of the Uveal Tract. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1509968"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.21873\/anticanres.17817","article-title":"Clinical Applications of Artificial Intelligence in Uveal Melanoma","volume":"45","author":"Chadwick","year":"2025","journal-title":"Anticancer Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41698-017-0039-5","article-title":"The Potential of Liquid Biopsies for the Early Detection of Cancer","volume":"1","author":"Heitzer","year":"2017","journal-title":"npj Precis. Oncol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Iddir, S.P., Love, J., Ma, J.S., Bryan, J.M., Ganesh, S., Heiferman, M.J., and Yi, D. (2023). Predicting Malignant Transformation of Choroidal Nevi Using Machine Learning. Res. Sq.","DOI":"10.21203\/rs.3.rs-3778562\/v1"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41698-021-00216-w","article-title":"Artificial Intelligence for the next Generation of Precision Oncology","volume":"5","author":"Ballester","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"bbaf440","DOI":"10.1093\/bib\/bbaf440","article-title":"Deep Learning-Driven Multi-Omics Analysis: Enhancing Cancer Diagnostics and Therapeutics","volume":"26","author":"Zhang","year":"2025","journal-title":"Brief. Bioinform."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Qoronfleh, M.W., and Al-Dewik, N. (2025). Cancer Biomarkers: Reflection on Recent Progress, Emerging Innovations, and the Clinical Horizon. Cancers, 17.","DOI":"10.3390\/cancers17182981"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e202301955","DOI":"10.26508\/lsa.202301955","article-title":"SF3B1 Mutation-Mediated Sensitization to H3B-8800 Splicing Inhibitor in Chronic Lymphocytic Leukemia","volume":"6","author":"Gohr","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"107735","DOI":"10.1016\/j.leukres.2025.107735","article-title":"Phase 1 First-in-Human Dose-Expansion Study of the Oral SF3B1 Modulator H3B-8800 in Lower-Risk Myelodysplastic Syndrome","volume":"156","author":"Foran","year":"2025","journal-title":"Leuk. Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12943-025-02477-6","article-title":"Turning Cold Tumors into Hot Tumors to Ignite Immunotherapy","volume":"24","author":"Liu","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41591-021-01672-4","article-title":"A Roadmap to Increase Diversity in Genomic Studies","volume":"28","author":"Fatumo","year":"2022","journal-title":"Nat. Med."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/2\/131\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T09:04:54Z","timestamp":1769418294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/2\/131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":180,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["cimb48020131"],"URL":"https:\/\/doi.org\/10.3390\/cimb48020131","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]}}}